Untersuchung des Wirkmechanismus der Sangpi-Hustensaft-Formel bei der Behandlung von Husten nach RSV-Infektion basierend auf „gleichzeitiger Behandlung von Lunge und Darm“

  • role: First author第一作者
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847, China

  • Email:2983146721@qq.com
  • Introduction:索闯,在读硕士,从事中西医结合防治小儿肺系疾病的临床与基础研究,E-mail:2983146721@qq.com
SUO Chuang1,  
  • role: Corresponding author通信作者
  • Affiliation:

    Affiliated Hospital of Liaoning University of TCM, Shenyang 110032, China

  • Email:lunwen200901@yeah.net
  • Introduction:白晓红,硕士,教授,博士生导师,主任医师,从事中西医结合防治小儿各系统疾病的临床与基础研究,E-mail:lunwen200901@yeah.net
BAI Xiaohong2*,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847, China

YU Zhitong1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847, China

GONG Xue1,  
  • Affiliation:

    Affiliated Hospital of Liaoning University of TCM, Shenyang 110032, China

XIU Chan2,  
  • Affiliation:

    Affiliated Hospital of Liaoning University of TCM, Shenyang 110032, China

LYU Qihui2,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847, China

LIU Zhihui1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM), Shenyang 110847, China

LI Kelin1

Resümee

Ziel der Studie ist die Untersuchung des Wirkmechanismus der Sangpi-Hustensaft-Formel bei der Behandlung von Husten nach einer Infektion mit dem Respiratorischen Synzytial-Virus (RSV) mittels der "gleichzeitigen Behandlung von Lunge und Darm" basierend auf Netzwerkpharmakologie und Tierversuchen. Die aktiven Inhaltsstoffe und ihre Ziele wurden aus der TCMSP-Datenbank bezogen; Krankheitsziele aus GeneCards und OMIM. Nach Überschneidung der Ziele wurden Protein-Interaktionsnetzwerke und ein Netzwerk aus Medikament-Komponente-Ziel aufgebaut, um Kernziele zu ermitteln. GO- und KEGG-Enrichmentsanalysen wurden an den Schnittmengen durchgeführt. Es wurden 60 Mäuse verwendet: 10 Normalgruppen und 50 Infizierte mit RSV durch nasale Tropfen, induziertem Husten durch Capsaicin. Die Modellmäuse wurden in Modellgruppe, Montelukast-Gruppe (1 mg·kg⁻¹·Tag⁻¹) und drei Sangpi-Gruppen mit niedriger, mittlerer und hoher Dosis (4,875, 9,75, 19,5 g·kg⁻¹·Tag⁻¹) zu je 10 Tieren eingeteilt. Ab Tag 14 nach RSV-Infektion erhielten Normal- und Modellgruppe physiologische Kochsalzlösung, die anderen die entsprechenden Medikamente oral, 1x täglich für 5 Tage. HE-Färbung wurde zur Untersuchung von Lungen- und Dickdarmgewebe durchgeführt; Western Blot für ERK1/2 und p-ERK1/2; Echtzeit-PCR für ERK1/2-mRNA-Expression; Immunhistochemie für p-MEK1/2, p-ERK1/2, p-c-Fos, IL-4 und TNF-α. Die Netzwerkpharmakologie identifizierte 184 aktive Komponenten und 684 Zielproteine der Formel, 1344 RSV-bezogene Ziele, 209 Schnittstell-Ziele, darunter TNF, Fos, Jun. KEGG-Analyse fand 179 Signalwege, u.a. MAPK, Krebs, TNF, IL-17. Tierversuche zeigten typische Entzündungsschäden, Zelleinwanderung, Zerstörung enger Zellkontakte und signifikant erhöhte p-ERK1/2, ERK1/2 und mRNA. Im Vergleich zur Modellgruppe verbesserte Sangpi-Hustensaft deutlich die Entzündungen und reduzierte die Expression von ERK-Signalproteinen. Fazit: Sangpi-Hustensaft hemmt den ERK-Signalweg und reduziert Gewebeschäden in Lunge und Darm, was zur Behandlung von Husten und darmbezogenen Symptomen nach RSV-Infektion beiträgt.

Schlüsselwort

Sangpi-Hustensaft-Formel;Gleichzeitige Behandlung von Lunge und Darm;Respiratorisches Synzytial-Virus (RSV);Postinfektiöser Husten;Signalwege

References

  1. 1.
    JIANG M Y,DUAN Y P,TONG X L,et al.Clinical manifestations of respiratory syncytial virus infection and the risk of wheezing and recurrent wheezing illness:A systematic review and Meta-analysis[J].World J Pediatr,2023,19(11):1030-1040.
  2. 2.
    BARDSLEY M,MORBEY R A,HUGHES H E,et al.Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic,measured by laboratory,clinical,and syndromic surveillance:A retrospective observational study[J].Lancet Infect Dis,2023,23(1):56-66.
  3. 3.
    YAGI K,LUKACS N W,HUFFNAGLE G B,et al.Respiratory and gut microbiome modification during respiratory syncytial virus infection:A systematic review[J].Viruses,2024,16(2):220.
  4. 4.
    ZHANG Y W,YUAN L C,ZHANG Y M,et al.Burden of respiratory syncytial virus infections in China:Systematic review and Meta-analysis[J].J Glob Health,2015,5(2):020417.
  5. 5.
    ZHENG B R.The clinical characteristics and TCM syndrome type distribution of RSV infection in children[D].Jinan:Shandong University of Traditional Chinese Medicine,2016.
  6. 6.
    WANG X F,LIU E M.Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment ofpost-infectious cough(PIC)with respiratory tract in children(2024 Edition)[J].Chin J Pract Pediatr,2024,39(9):652-658.
  7. 7.
    DE OLIVEIRA G L V,OLIVEIRA C N S,PINZAN C F,et al.Microbiota modulation of the gut-lung axis in COVID-19[J].Front Immunol,2021,12:635471.
  8. 8.
    ZHU W X,WU Y L,LIU H,et al.Gut-lung axis:Microbial crosstalk in pediatric respiratory tract infections[J].Front Immunol,2021,12:741233.
  9. 9.
    WANG X H,SHI J,ZHANG M Y,et al.Mechanism of Qingfei Huatan Zhuyu decoction in treatment of COPD based on "lung and intestinal co-treatment"[J].Chin J Exp Tradit Med Form,2024,30(4):124-133.
  10. 10.
    BAO S C,YAN S G,CHEN T,et al.Combined therapy of lung and intestine in treatment of lung diseases:A review[J].Chin J Exp Tradit Med Form,2022,28(8):116-122.
  11. 11.
    KOU Y L,WANG W B,YAN S G,et al.Mechanism of lung and intestine combination therapy in treatment of acute lung injury by inhibiting inflammatory response based on NF-κB/NLRP3 signaling pathway and alveolar macrophage activation[J].China J Chin Mater Med,2022,47(1):151-158.
  12. 12.
    LYU S S,BAI X H,LIU F,et al.Clinical observation on the effect of Sangpi Zhike decoction to treat the children's post infectious cough of lungs heat retention pattern[J].J Liaoning Univ Tradit Chin Med,2016,18(4):95-97.
  13. 13.
    WANG M,BAI X H,LIU F,et al.Effects of Sangpi Zhike prescription on expression of c-Fos protein and related inflammatory factors in RSV-induced mice with cough after infection[J].Chin J Tradit Chin Med Pharm,2020,35(12):6038-6042.
  14. 14.
    LUO J S,MA J L,LUO J Y,et al.Research progress in animal models of cough[J].Chin J Comp Med,2023,33(9):99-112.
  15. 15.
    GAO L,WANG J,DENG Y.Research status and approaches of the theory "the lung and large intestine are interior-exteriorly related"[J].J Tradit Chin Med,2012,53(4):291-294.
  16. 16.
    MA S L.Analysis of the patterns and treatment principles of the theory "the lung and large intestine are interior-exteriorly related" based on three editions of Mingyi Leian (famous medical case records) and infrared thermography[D].Beijing:Beijing University of Chinese Medicine,2013.
  17. 17.
    ZHENG X L,YANG Y,TANG H Q,et al.Exploring the theory of "the lung and large intestine being interior-exteriorly related" through the lung's regulation of bowel movements[J].Lishizhen Med Mater Med Res,2013,24(2):429-430.
  18. 18.
    JING T Y,WANG P,DU H T,et al.Exploring the anti-RSV mechanisms of heat-clearing herbs based on the theory "the lung and large intestine are interior-exteriorly related"[J].Mod Tradit Chin Med Mater Med-World Sci Technol,2022,24(10):3659-3666.
  19. 19.
    GEORGIOU K,MARINOV B,AHMAD FAROOQI A,et al.Gut microbiota in lung cancer:Where do we stand?[J].Int J Mol Sci,2021,22(19):10429.
  20. 20.
    TULIC M K,PICHE T,VERHASSELT V.Lung-gut cross-talk:Evidence,mechanisms and implications for the mucosal inflammatory diseases[J].Clin Exp Allergy,2016,46(4):519-528.
  21. 21.
    WANG J,LI F Q,WEI H M,et al.Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation[J].J Exp Med,2014,211(12):2397-2410.
  22. 22.
    MATSUMOTO H,KIMURA Y,MURAO T,et al.Severe colitis associated with both Epstein-Barr virus and cytomegalovirus reactivation in a patient with severe aplastic anemia[J].Case Rep Gastroenterol,2014,8(2):240-244.
  23. 23.
    ELSAED W M.Amygdalin (Vitamin B17) pretreatment attenuates experimentally induced acute autoimmune hepatitis through reduction of CD4+ cell infiltration[J].Ann Anat,2019,224:124-132.
  24. 24.
    BADR EL-KHOLY W,ABDEL-RAHMAN S A,ABD EL-HADY EL-SAFTI F E,et al.Effect of vitamin B17 on experimentally induced colon cancer in adult male albino rat[J].Folia Morphol (Warsz),2021,80(1):158-169.
  25. 25.
    IBRAHIM S,ZHU X,LUO X L,et al.PIK3R3 regulates ZO-1 expression through the NF-κB pathway in inflammatory bowel disease[J].Int Immunopharmacol,2020,85:106610.
  26. 26.
    LI J J,HUANG Y J,LI Y D,et al.Therapeutic effect and mechanism of arctigenin on dextran sodium sulfate induced inflammatory bowel disease in mice[J].Chin J Immunol,2023,39(10):2166-2170.
  27. 27.
    SHEN Y,LYU B.Study of glycyrrhizin regulating Caspase-12 apoptosis signaling pathway of endoplasmic reticulum stress to alleviate the colonic inflammatory response in ulcerative colitis[J].China J Tradit Chin Med Pharm,2020,35(8):3872-3877.
  28. 28.
    SCHMITT K R L,DIESTEL A,LEHNARDT S,et al.Hypothermia suppresses inflammation via ERK signaling pathway in stimulated microglial cells[J].J Neuroimmunol,2007,189(1-2):7-16.
  29. 29.
    ZHAO Y,YANG J H,HAN J P,et al.Research progress of MEK/ERK pathway in bronchial asthma pathogenesis[J].China Arch Tradit Chin Med,2017,35(2):329-331.
  30. 30.
    LIM D H,CHO J Y,MILLER M,et al.Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice[J].Am J Physiol Lung Cell Mol Physiol,2006,291(2):L265-L271.
  31. 31.
    REN L P,LI X J,JIN S J,et al.Investigating the mechanism of lycorine-regulated apoptosis in HepG-2 hepatoma cellsviathe Raf/MEK/ERK signaling pathway and ROS levels[J].Pharmacol Clin Chin Mater Med,2021,37(2):28-32.
  32. 32.
    REDHU N S,SHAN L Y,AL-SUBAIT D,et al.IgE induces proliferation in human airway smooth muscle cells:Role of MAPK and STAT3 pathways[J].Allergy Asthma Clin Immunol,2013,9(1):41.
  33. 33.
    TANG F,PACHECO M T F,CHEN P,et al.Secretogranin Ⅲ promotes angiogenesis through MEK/ERK signaling pathway[J].Biochem Biophys Res Commun,2018,495(1):781-786.
  34. 34.
    FANG X M,LIU J,YAN Z Y,et al.Effect mechanism research on Pingchuanning intervening asthma airway remodeling by regulation of Ras,MEK1 and c-Fos related protein in ERK signaling pathway[J].Chin J Tradit Chin Med Pharm,2019,34(1):295-297.
  35. 35.
    SONG P F,SHANG L L,TIAN J Y.Effects of Jianpi Bufei Huatan decoction on the expression of TGF-β1,c-Fos in lung tissue of asthma rat[J].J Liaoning Univ Tradit Chin Med,2017,19(4):23-26.
  36. 36.
    CHAN J L.Experimental study on the effects of Sangpi Zhike prescription on IL-4,IFN-γ,and NGF levels in BALB/c mice with RSV-induced cough[D].Shenyang:Liaoning University of Traditional Chinese Medicine,2020.
  37. 37.
    QIN L,TAN Y R,HU C P,et al.Leptin is oversecreted by respiratory syncytial virus-infected bronchial epithelial cells and regulates Th2 and Th17 cell differentiation[J].Int Arch Allergy Immunol,2015,167(1):65-71.
  38. 38.
    ZHENG X R,YANG Y,ZHENG X L,et al.Investigating the theory of "the lung and large intestine being interior-exteriorly related" through changes in the ERK signaling pathway in the lung and intestine[J].Chin Tradit Pat Med,2014,36(11):2388-2390.
  39. 39.
    SUN Y,LIU W Z,LIU T,et al.Signaling pathway of MAPK/ERK in cell proliferation,differentiation,migration,senescence and apoptosis[J].J Recept Signal Transduct Res,2015,35(6):600-604.
  40. 40.
    CHEN X Y,LUO Y H,WANG M Q,et al.Effect of Kechuanning on airway remodeling and protein level of p-ERK1/2 in lung tissues of asthmatic rats induced by virus[J].Chin J Pathophysiol,2019,35(7):1268-1275.
  41. 41.
    HAUNG S Q,LU A N,WANG D L,et al.Study on the repair mechanism of Shaoyao decoction on mucosal barrier in ulcerative colitis based on MAPK/ERK pathway[J].J Zhejiang Chin Med Univ,2022,46(12):1301-1309,1319.
  42. 42.
    MA X P,WANG X,SI L J,et al.Anti-respiratory syncytial virus effects and mechanism on the innate immune signaling pathway of Compound Yizhihao granules in vitro[J].West China J Pharm Sci,2024,39(4):371-376.
  43. 43.
    LIANG Y X.Effects of ganciclovir combined with methylprednisolone on serum IgE and IL-4 levels and oxygen saturation in children with RSV-associated bronchiolitis[J].Matern Child Health Care China,2023,38(7):1236-1239.
  44. 44.
    DONG X Y.Study on the changes of serum IL-4,IL-33 and IFN-γ in infants with lower respiratory tract infection caused by RSV[D].Dalian:Dalian Medical University,2021.
  45. 45.
    ZHENG X L.To explore the biological basis of the mass change of the lung and large intestine in pathological state based on the lungs and intestinal microflora and MEK/ERK signaling pathway[D].Chengdu:Chengdu University of Traditional Chinese Medicine,2013.
  46. 46.
    CHEN S W,ZHU J,ZUO S,et al.Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers[J].Inflamm Res,2015,64(10):789-797.
  47. 47.
    ZHAO J,WAN S X,SUN N,et al.Damage to intestinal barrier integrity in piglets caused by porcine reproductive and respiratory syndrome virus infection[J].Vet Res,2021,52(1):93.

Lesen Sie die ganze Passage

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website